What is Skipta?
Skipta operates as a premier social network dedicated to verified healthcare professionals, offering a secure environment for clinical collaboration and professional discourse. The platform serves as a vital bridge between pharmaceutical organizations and the medical community, providing a suite of marketing solutions that prioritize trust and relevance. By integrating brand content into peer-to-peer discussions, Skipta enables life science companies to engage with HCPs in a manner that is both compliant and highly effective. The company's market position is defined by its ability to curate specialty-specific environments, ensuring that messaging is delivered to the most relevant clinical audiences, thereby driving measurable outcomes for its enterprise clients.
How much funding has Skipta raised?
Skipta has raised a total of $2.5M across 1 funding round:
Series A
$2.5M
Series A (2014): $2.5M with participation from Mansa Capital
Key Investors in Skipta
Mansa Capital
A private equity firm focused on the healthcare sector, specializing in growth-stage investments that drive operational excellence and market expansion.
What's next for Skipta?
With the successful closure of this major strategic investment, Skipta is well-positioned to accelerate its product development and deepen its penetration into the global healthcare market. The company is expected to leverage this capital to enhance its proprietary engagement tools, potentially incorporating advanced analytics to further refine the efficacy of its marketing solutions. As the firm continues to scale, the focus will likely remain on maintaining the integrity of its verified user base while expanding its footprint in emerging medical specialties. This growth trajectory suggests a long-term commitment to evolving the digital ecosystem for healthcare communication, ensuring that pharmaceutical partners can continue to deliver high-value content within a trusted, professional framework.
See full Skipta company page
